Cell cycle changes in ovarian cancer after arabinosylcytosine.
D000230:Adenocarcinoma / Q000188:drug therapy*; D001201:Ascites / Q000209:etiology; D001202:Ascitic Fluid / Q000032:analysis / Q000166:cytology*; D001345:Autoradiography; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects*; D002467:Cell Nucleus; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007621:Karyotyping; D007700:Kinetics; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*
D003561:Cytarabine; D005947:Glucose